Tenaya Therapeutics
why we do what we do and why the time is now for next generation precision medicine therapies for heart disease | Tenaya Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
7 of 36
Related slides by other companies
Evotec
Investor Presentation
March 2024
together for medicines that matter coy | Evotec
Exscientia
Investor Presentation
March 2024
trials expansion of precision medicine platform a i | Exscientia
Fusion Pharmaceuticals
IPO
June 2020
fusion next generation for precision oncology | Fusion Pharmaceuticals
BenevolentAI
Investor Day
September 2022
our precision medicine approaches are applied to multiple stages of our pipeline and can support activities precision medicine enabled target indication mapping additional indications a target or drug approved or in development through the cation of additional disease indications address additional unmet need the value of a target or drug identifying key patient cohorts and responders for drugs clinical development increase probability of success improve outcomes for patients cation of patient cohorts responders trial design patient outcomes for each indication | BenevolentAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights